Pablo Ortiz-Romero

16PUBLICATIONS
87CO-AUTHORS
Predictive and prognostic markersMolecular medicineHaematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 15, 2025
A new prognostic index (CLIPI) for advanced cutaneous lymphoma enables precise patient risk stratification.

Julia J Scarisbrick, Pietro Quaglino, Sean Whittaker

|Jun 19, 2025
Comparative effect of metformin and SGLT2i on vascular risk and mortality in hidradenitis suppurativa.

Alfonso Gotor-Rivera, Julia Hernández-Sánchez, Eva Chamorro-Jiménez

|Oct 13, 2022
Chlormethine Gel for the Treatment of Mycosis Fungoides Cutaneous T-Cell Lymphoma: In Vitro Release and Permeation Testing.

Claudio Giuliano, Stefano Frizzarin, Alessandro Alonzi

|Apr 15, 2022
Real-life experience of using pegylated liposomal doxorubicin in primary cutaneous T-cell lymphomas.

Daniel Falkenhain-López, Mario Puerta-Peña, Jon Fulgencio-Barbarin

|Nov 11, 2021
Live imaging of neolymphangiogenesis identifies acute antimetastatic roles of dsRNA mimics.

David Olmeda, Daniela Cerezo-Wallis, Cynthia Mucientes

|Nov 10, 2021
Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC.

Elise A Olsen, Sean Whittaker, Rein Willemze

Pageof 3

Frequent Collaborators

5 joint publications

Julia Scarisbrick

3 joint publications

Jose Antonio Sanches

3 joint publications

Cristina Vico-Alonso

3 joint publications

Youn H Kim